Cormorant Private Healthcare Fund IV LP, 10% Owner at MoonLake Immunotherapeutics (MLTX), bought 586,424 shares at $57.32 ($33.6M) on 2023-10-04, disclosed to the SEC on 2023-10-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.37 | 74,911 | $4.3M | 12.8% |
| 2 | $57.37 | 74,911 | $4.3M | 12.8% |
| 3 | $57.25 | 150,487 | $8.6M | 25.6% |
| 4 | $57.25 | 150,487 | $8.6M | 25.6% |
| 5 | $57.32 | 67,814 | $3.9M | 11.6% |
| 6 | $57.32 | 67,814 |
| $3.9M |
| 11.6% |
| Total | $57.30 avg | 586,424 | $33.6M | 100% |